LEADER 03108nam 22004455 450 001 9910254270303321 005 20200629211851.0 010 $a3-319-32794-1 024 7 $a10.1007/978-3-319-32794-5 035 $a(CKB)3710000000765382 035 $a(DE-He213)978-3-319-32794-5 035 $a(MiAaPQ)EBC4614802 035 $a(PPN)194516814 035 $a(EXLCZ)993710000000765382 100 $a20160727d2016 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aGuide to Clinical Management of Idiopathic Pulmonary Fibrosis /$fby Steven D Nathan, A Whitney Brown, Christopher S King 205 $a1st ed. 2016. 210 1$aCham :$cSpringer International Publishing :$cImprint: Adis,$d2016. 215 $a1 online resource (XVII, 123 p. 18 illus., 12 illus. in color.) 311 $a3-319-32792-5 320 $aIncludes bibliographical references at the end of each chapters. 327 $aOverview of idiopathic pulmonary fibrosis -- Clinical presentation and diagnosis -- Diseases that mimic idiopathic pulmonary fibrosis -- Pathogenesis idiopathic pulmonary fibrosis -- Prognosis, clinical course, and monitoring of patients with idiopathic pulmonary fibrosis -- Comorbidities and complications of idiopathic pulmonary fibrosis -- Treatment of idiopathic pulmonary fibrosis -- Non-pharmacologic management of idiopathic pulmonary fibrosis -- The future of idiopathic pulmonary fibrosis. 330 $aThis clinically focused pocket guide offers a concise yet complete overview of idiopathic pulmonary fibrosis, covering the most recent information on aspects such as pathophysiology, management, treatment, and clinical trials. The text is easily accessible and offers pulmonologists and other health care professionals with an excellent quick reference tool. Full color images and figures enhance and summarize key aspects of the text. Idiopathic pulmonary fibrosis is a condition that affects the alveoli and leads to serious lung damage, and the idiopathic nature of this disease means that the origin or cause is unknown. This disease is relatively rare, affecting 3 in 10,000 people, but it is becoming more common. Physicians should be aware of the early stages and symptoms of this disease so management strategies can be implemented quickly, and the best treatment can be administered. 606 $aRespiratory organs?Diseases 606 $aPneumology/Respiratory System$3https://scigraph.springernature.com/ontologies/product-market-codes/H33134 615 0$aRespiratory organs?Diseases. 615 14$aPneumology/Respiratory System. 676 $a616.2 700 $aNathan$b Steven D$4aut$4http://id.loc.gov/vocabulary/relators/aut$01061346 702 $aBrown$b A Whitney$4aut$4http://id.loc.gov/vocabulary/relators/aut 702 $aKing$b Christopher S$4aut$4http://id.loc.gov/vocabulary/relators/aut 906 $aBOOK 912 $a9910254270303321 996 $aGuide to Clinical Management of Idiopathic Pulmonary Fibrosis$92518512 997 $aUNINA